These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8436508)

  • 1. [Local lipohypertrophy in insulin treatment].
    Herold DA; Albrecht G
    Hautarzt; 1993 Jan; 44(1):40-2. PubMed ID: 8436508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of type-1 diabetics with insulin-induced lipohypertrophy by liposuction].
    Hauner H; Olbrisch RR
    Dtsch Med Wochenschr; 1994 Mar; 119(12):414-7. PubMed ID: 8143555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin induced lipohypertrophy and glomerulonephritis in an insulin dependent diabetic.
    Dandona P; Mier A; Boag F; Chappell M; Beckett AG
    Diabetes Res; 1985 Jul; 2(4):213-6. PubMed ID: 2417774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human insulin-induced lipoatrophy].
    Jermendy G; Nádas J; Sápi Z
    Orv Hetil; 2000 Oct; 141(44):2393-6. PubMed ID: 11105557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human insulin and lipoatrophy.
    Page MD; Bodansky HJ
    Diabet Med; 1992 Oct; 9(8):779. PubMed ID: 1395476
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.
    Schober E; Rami B
    Pediatr Diabetes; 2009 May; 10(3):198-201. PubMed ID: 19175897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine insulin therapy and lipohypertrophy.
    Mahadevan S; Bhadada SK; Velayutham P; Bhansali A
    Arch Dis Child; 2004 Jul; 89(7):624. PubMed ID: 15210491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic.
    Boag F; Chappell M; Beckett AG; Dandona P
    N Engl J Med; 1985 Jan; 312(4):245-6. PubMed ID: 2578215
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of insulin lipoatrophy. A case report.
    Asherov J; Mimouni M; Laron Z
    Diabete Metab; 1979 Mar; 5(1):1-3. PubMed ID: 571820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin-induced lipoatrophy in children].
    Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
    Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII).
    Jarosz-Chobot P; Nowakowska M; Polanska J
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):179-81. PubMed ID: 17427107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe insulin-induced lipohypertrophy successfully treated by liposuction.
    Hardy KJ; Gill GV; Bryson JR
    Diabetes Care; 1993 Jun; 16(6):929-30. PubMed ID: 8325209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.